How is Dexcom (DXCM) doing?

Dexcom is a company in the medical, devices industry, based in San Diego, CA, worth $31.7B. Here is how its shares and business compare with the rest of the market, and where it shows up on our dashboards.

Updated Oct 9, 2026

P3 score

Strong

Dexcom shares are up 24% over the past year, 7 points ahead of the S&P 500. Its type is Hot Hand. Among large US stocks and funds it ranks in the 79th percentile on market beat, the 42nd on staying power and the 96th on business growth. It appears on 10 of our dashboards.

$84.11+24% in a yearWorth $31.7B

Compare with ABT · MDT · PODD · RMD

Financials, earnings and news on Stox ›

Past year

The past year

Price against the S&P 500, each set to $100 a year ago. Score is its weekly rank against the market. Select a tile for that score month by month.

DXCM against the S&P 500, past year

$100 a year ago. Dexcom +24%, the S&P 500 +16%.

DXCMS&P 500

What kind of stock is it?

Its type on Stox Atlas, from its four scores: beating or lagging the market, a steady or erratic rank, a growing or slowing business, and whether buyers or sellers lead.

Hot Hand

BeatingErraticGrowingBought

Beating the market on a growing business with buyers adding, but its rank swings from week to week.

NovDecJanFebMarAprMayJunJulAugSepNow

Hot Hand this month; Turning Up before that.

Also Hot Hand (59 in all): GMED · HALO · LH · NVST · ABBV · EW

EmbracedToppingAccumulatingRejectedStable rankBellwetherDistribution TopCoiled SpringWallflowerHolding rankFaith TradeRolling OverBottom FishedSleepy StapleUnsteady rankHot HandChurning WinnerTurning UpShow-Me GrowerBouncy rankSpeculative PopExhausted RallyFalling KnifeBroken Year

How is it doing against its group?

Its group is Health care, 86 large US stocks and funds whose prices tend to move together. Tools, biotech and large-cap pharma — defensive growth.

DXCM, past year+24%31 of 86 in the group

Rest of the group+20%equal-weighted

S&P 500+16%past year

Dexcom is +24% over the past year, against +20% for the rest of the group and +16% for the S&P 500. It ranks 31st of 86 in Health care.

DXCMRest of the group

Best in the groupRVMD Revolution Medicines+297%ILMN Illumina+184%NTRA Natera+133%

Worst in the groupPODD Insulet−57%BSX Boston Scientific−56%RARE Ultragenyx−50%

Its closest rivalsABT Abbott Laboratories−26%MDT Medtronic−10%PODD Insulet−57%

Health care on Stox ›

How much does it move?

Its typical daily move, against its own past year, the market and other large stocks. Swings describe risk, not direction.

Calmer than usual Dexcom typically moves 2.7% in a day, calmer than usual for it, and it swings more than 62% of large US stocks.

Typical day2.7%about $2.26 a share

Its usual3.5%calmer than usual, 0.8× its year’s average

Against the S&P 5003.1×the index’s typical day is 1.1%

Unusual day±5.4%twice its typical day

Deepest fall, past year−23%now 9% below its high

In the S&P’s down weeks94%of the index’s fall, three years; beta 0.9

Typical daily move (ATR)Its year’s average 3.48%

DXCM on our dashboards

Every question where Dexcom appears, in the order of the home page, with its reading and place in that table. Select a question to open it with DXCM highlighted. Select a column to sort.

Question	Reading	Place	Details
How much do stocks move on earnings? Earnings	86Big mover	57 of 60	Reports 2026-10-29 · Typical move 8.3% · Largest 15%
Which stocks show persistent price growth and business growth? Leading stocks	68Strong	49 of 60	Pressure 96 · 1Y +24%
Which companies grow earnings every year? Business quality	89Building	55 of 60	Years of growth 4 years · Growth, 5Y +10% a yr · Latest EPS 2.09
Whose profit margins are widening? Business quality	89Widening	45 of 60	Change, 1Y +6.9 pts · Operating margin 23% · Gross margin 62%
Which businesses are getting better? Business quality	96Improving	19 of 60	Revenue growth +16% · Cash-flow growth +149% · Operating margin 21%
Which companies earn the most on their capital? Business quality	90Excellent	42 of 60	Return on capital 22% · Gross margin 62% · Cash margin 28%
Which stocks are cheap against their own history? Value	96Cheap	58 of 60	P/E now 33.2x · 10-yr median 186.7x · Earnings, 1Y +76%
Which companies have more cash than debt? Value	89Net cash	44 of 60	Net cash $600.9M · % of value +2% · Debt payback 1.0 yrs
What are insiders buying? Who’s buying and selling	65Selling	24 of 60	Sold $221K · Who EVP Chief People & Culture Off
Where is money flowing in? Who’s buying and selling	96Inflow	19 of 60	30 days 87 · 5 days 71 · Net buying +21%

Go deeper on Stox

DXCM’s full profile: financial statements, earnings and analysts’ estimates, valuation against its sector, recent news with a summary, and its scores in detail.

Open DXCM on Stox ›All 16 types on Atlas ›Its group on Stox ›

How to read this page

How it’s measured. Scores from Stox rank the stock against about 1,200 S&P 500, Nasdaq-100 and Russell 1000 stocks and popular funds, where 100 is best; market beat and staying power use prices, business growth uses revenue, margins and cash flow. Readings on other dashboards come from this site’s pages.

Sources. Daily prices and company financial statements from Financial Modeling Prep; scores and co-movement groups from Stox.

Scores are percentiles: 80 means the stock ranks above 80% of the others on that measure. They describe the recent past and are not advice or a forecast.

Its type follows Stox Atlas: each of the four scores is split at 50. “Steady” means its rank has held, high or low, so it says nothing on its own about direction.

Its group is the cluster of large US stocks whose prices have moved together over five years, with the market’s own moves taken out. The typical daily move is the average true range over 14 days, a measure of how far the price travels in a day including overnight gaps.

For financial statements, earnings and news, see DXCM’s full profile on Stox.

This page is information, not investment advice. About our data and methods ›

Full profile on Stox ›Health care stocks ›ABT · Abbott Laboratories ›MDT · Medtronic ›PODD · Insulet ›